This site is intended for healthcare professionals only
LoginRegister
Zydus Secures CDSCO Panel Go-Ahead For Phase III Trial of Empagliflozin-Metoprolol FDCZydus Secures CDSCO Panel Go-Ahead For Phase III Trial of Empagliflozin-Metoprolol FDC
Karandeep Singh DuggalReckitt names Karandeep Singh Duggal as new Region Head-Central India
CiplaCipla inks pacts to invest in iCaltech Innovations
Takeda announces closing of partnership with Innovent Biologics for oncology medicinesTakeda gets USFDA 510(k) clearance for HyHub, HyHub Duo devices to simplify HYQVIA administration
Dr Reddys Russia Arm Slapped Rs 2.45 Cr VAT PenaltyDr Reddy's Labs gets USFDA EIR for New York facility
JnJ completes acquisition of Halda Therapeutics, its novel platform for cancer treatmentSanofi to expand respiratory vaccines pipeline with acquisition of Vicebio
Torrent Pharma Gets Zero USFDA Observations for Dahej PlantJnJ seeks USFDA approval for Icotrokinra to treat plaque psoriasis in adults, adolescents
Bayer-Regeneron Aflibercept 8 mg recommended for EU approval for third retinal indicationBayer Nubeqa gets EU nod in third indication for advanced prostate cancer
1-Year Ban for Fake Docs, Mandatory Disposal of Near-Expiry Stock: CDSCO Revises Pharma Export Rules1-Year Ban for Fake Docs, Mandatory Disposal of Near-Expiry Stock: CDSCO Revises Pharma Export Rules
MSD Pharma Gets Conditional SEC Approval to Begin Phase III Trial of Sacituzumab TirumotecanCDSCO Panel Nod To MSD's Sotatercept Label Change, Expands Prescribing Rights to Cardiologists
George Tidmarsh named Director of Center for Drug Evaluation and Research: USFDAGeorge Tidmarsh named Director of Center for Drug Evaluation and Research: USFDA
Jubilant Ingrevia appoints Ahmad Nadeem KhanJubilant Ingrevia appoints Ahmad Nadeem Khan as Senior Director - Procurement
X